Updates are available Correction dated 2018-03-08
Click to view Correction: https://doi.org/10.1038/s41380-018-0032-6
-
Authors
Kraus, Christoph http://orcid.org/0000-0002-7144-2282
Klöbl, Manfred
Tik, Martin http://orcid.org/0000-0002-6571-4413
Auer, Bastian
Vanicek, Thomas
Geissberger, Nicole
Pfabigan, Daniela M. http://orcid.org/0000-0002-4043-1695
Hahn, Andreas
Woletz, Michael
Paul, Katharina
Komorowski, Arkadiusz http://orcid.org/0000-0002-1674-4333
Kasper, Siegfried
Windischberger, Christian
Lamm, Claus
Lanzenberger, Rupert http://orcid.org/0000-0003-4641-9539
- License Information
-
More Information
Article History
Received: 8 June 2017
Revised: 5 October 2017
Accepted: 27 October 2017
First Online: 8 February 2018
Change Date: 8 March 2018
Change Type: Correction
Change Details: The author list was presented as last name, first name. The names should have been listed as:Christoph Kraus, Manfred Klöbl, Martin Tik, Bastian Auer, Thomas Vanicek, Nicole Geissberger, Daniela M. Pfabigan, Andreas Hahn, Michael Woletz, Katharina Paul, Arkadiusz Komorowski, Siegfried Kasper, Christian Windischberger, Claus Lamm, Rupert Lanzenberger.
Compliance with ethical standards
:
: SK received grants/research support, consulting fees and/or honoraria within the last 3 years from Angelini, AOP Orphan Pharmaceuticals AG, AstraZeneca, Eli Lilly, Janssen, KRKA-Pharma, Lundbeck, Neuraxpharm, Pfizer, Pierre Fabre, Schwabe and Servier. RL received travel grants and/or conference speaker honoraria from AstraZeneca, Lundbeck A/S, Dr. Willmar Schwabe GmbH, Orphan Pharmaceuticals AG, Janssen-Cilag Pharma GmbH, and Roche Austria GmbH. TV received travel grants and compensation for workshop participation from Pfizer and Eli Lilly and speaker honoraria from Eli Lilly. CK has received travel grants from Roche Austria GmbH and AOP Orphan. The remaining authors declare that they have no conflict of interest.
